. 2020 Jun 22;69(10):1832–1840. doi: 10.1136/gutjnl-2020-321923

Table 6.

Characteristics of liver transplant recipients died because of COVID-19

Case	Sex (M/F)	Age, years	Ethnicity	BMI, kg/m²	Comorbidity	Symptoms at presentation	Immunosuppression management	Respiratory support	ICU admission
1	M	67	Caucasian	27.8	History of renal tumour	Fever, cough, dyspnoea	CNIs alone	NIMV	No
1	M	67	Caucasian	27.8	History of renal tumour	Fever, cough, dyspnoea	No change	NIMV	No
2	M	78	Caucasian	23.1	History of PTLD	Fever, cough, dyspnoea	CNIs alone	NIMV	No
					CV disease		No change
					Diabetes
					CKD
3	M	75	Caucasian	25.1	Active tumour: HCC recurrence	Dyspnoea,	CNIs alone	NIMV	No
					CV disease	Fatigue/myalgia	No change
					Arterial hypertension
4	M	55	Caucasian	21.6	–	Fever, dyspnoea	CNIs+steroids	NIMV	No
4	M	55	Caucasian	21.6	–	Fever, dyspnoea	Only CNIs discontinuation	NIMV	No
5	M	70	Caucasian	28.5	Active tumour: HCC recurrence	Fever, dyspnoea	CNIs+steroids	IMV	Yes
5	M	70	Caucasian	28.5	Arterial hypertension	Fever, dyspnoea	Only CNIs discontinuation	IMV	Yes
6	M	66	Caucasian	23.8	Active tumour: PTLD	Fever, cough, fatigue/myalgia, GI symptoms	Steroids	IMV	Yes
6	M	66	Caucasian	23.8	Arterial hypertension	Fever, cough, fatigue/myalgia, GI symptoms	No change	IMV	Yes
7	F	79	Caucasian	21.3	CV disease	Fever, dyspnoea, fatigue/myalgia	MMF alone	NC	No
					Diabetes
					Arterial hypertension
					CKD

CKD, chronic kidney disease; CNIs, calcineurin inhibitors; CV, cardiovascular; F, female; IMV, invasive mechanical ventilation; M, male; MMF, mycophenolate mofetil; NC, nasal cannula; NIMV, non-invasive mechanical ventilation; PTLD, post-transplant lymphoproliferative disorder.